Champions Oncology (CSBR) Reports Q4 Loss of $0.15/Share
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.96 -4.25%
Financial Fact:
Cost of personalized oncology solutions: 474K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Cost of personalized oncology solutions: 474K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of ($0.15), versus ($0.24) reported last year. Revenue for the quarter came in at $3.72 million, versus $2.8 million reported last year.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
